Clinical Trials for Io Therapeutics

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Actinium Therapy for Late-stage Aggressive Sarcomas

Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer

Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI

Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma